There are plenty of effective anticancer agents around. The problem is that, very often, they cannot gain access to all the cells in solid tumors. A new gene delivery vehicle may provide a way of making tracks to the heart of the target.
14 November, 2012
PharmaInformatic, a German biotech-company has developed a comprehensive knowledge base on bioavailability, which enables the targeted development of new drugs.
08 November, 2012
Today physicists at Wake Forest University and NanoMedica, their biotechnology company partner, received a $700,000 grant from the National Institutes of Health (NIH) to bring to market a new drug-discovery tool using next-generation genetic sequencing.
01 November, 2012